How Big Is the Malaria Vaccine Market | Size, Scope, and Projections 2025

How Big Is the Malaria Vaccine Market?

The market is gaining rapid traction with the rollout of WHO-approved malaria vaccines, especially in sub-Saharan Africa. Rising support from GAVI, UNICEF, and national immunization programs is accelerating distribution.

Growth Factors of the Malaria Vaccine Market

• WHO Approval and Policy Support for Vaccine Roll-Out
• GAVI and UNICEF Funding for Procurement and Distribution
• Expanded vaccine uptake in endemic areas
• Increasing malaria-related child mortality burden
• Strong R&D pipeline with next-generation vaccine candidates
• Public-private partnerships spurring innovative approaches and access

Malaria Vaccine Market Trends

Key trends in the malaria vaccine market are emerging as staged roll-out plans evolve, companies increase their logistics and manufacturing capacities, and partnerships exist for cold chain distribution. Developers are also working on some promising multi-valent vaccines that will offer the opportunity to expand protection across variants of the parasite and across age groups.

Emerging Developments in the Malaria Vaccine Market

New innovations in the Malaria Vaccine Market involve next-gen mRNA-based malaria vaccines, combination vaccines for co-infection, and alignment with current immunization schedules. Strong early progress in pilot countries will lead to plans for more global roll-out in partnership with coordinated efforts.

List of Leading Companies in the Malaria Vaccine Market

Below is a comprehensive list of the leading market players driving growth in this sector –

1. Moderna, Inc.

Moderna is a biotechnology firm leveraging mRNA technology and is advancing a malaria vaccine candidate under development collaborations.

2. BioNTech SE

BioNTech, known for its mRNA expertise, is partnering on research to create innovative malaria vaccines targeting high-need regions.

3. Serum Institute of India

This organization is one of the world’s largest vaccine manufacturers and is producing the R21/Matrix-M malaria vaccine for wide-scale deployment.

4. GSK plc

GSK is a global biopharmaceutical company that developed RTS, S/AS01, the first malaria vaccine recommended by WHO for widespread use.

5. Novavax, Inc.

Novavax specializes in recombinant nanoparticle vaccines and is involved in developing next-generation malaria vaccines.

6. Sanaria Inc.

Sanaria focuses exclusively on malaria and is pioneering whole-parasite vaccine approaches, including its PfSPZ vaccine platform.

7. Oxford University’s Jenner Institute

The Jenner Institute played a key role in developing the R21/Matrix-M vaccine, which shows high efficacy against malaria in clinical trials.

8. PATH (Program for Appropriate Technology in Health)

PATH is a global nonprofit organization supporting malaria vaccine development, policy advocacy, and large-scale pilot implementations.

9. Infectious Disease Research Institute (IDRI)

IDRI is engaged in innovative vaccine research, including adjuvants and delivery systems to support malaria immunization solutions.

10. Bharat Biotech

Bharat Biotech is involved in the research and potential co-development of malaria vaccines for tropical regions, with a focus on scalable solutions.

How Big Is the Malaria Vaccine Market : FAQ's